Sequential immunohistochemistry: a promising new tool for the pathology laboratory

Michiel van den Brand1, Brigiet M Hoevenaars, Jessica H M Sigmans

  • 1Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Histopathology
|April 29, 2014
PubMed

Insights

Sequential immunohistochemistry (S-IHC) enables studying multiple proteins in one tissue slide, overcoming limitations of current methods. This technique revealed discrepancies in lymphoma diagnoses, highlighting its diagnostic value.

Area of Science:

  • Histopathology
  • Immunohistochemistry
  • Oncology

Background:

  • Conventional immunohistochemistry (IHC) has limitations for multi-protein analysis in single tissue sections.
  • Sequential IHC (S-IHC) offers a novel solution for studying numerous proteins within one section with minimal optimization.

Purpose of the Study:

  • To introduce and validate sequential immunohistochemistry (S-IHC) as an improved method for multi-protein analysis.
  • To assess the utility of S-IHC in characterizing lymphomas.

Main Methods:

  • Tissue sections were stained sequentially with multiple antibodies, with intermediate scanning and elution of reagents.
  • Digital images were overlaid to enable simultaneous assessment of multiple protein expressions.
  • S-IHC was applied to nine nodular lymphocyte-predominant Hodgkin lymphomas (NLPHLs) and ten T-cell-rich/histiocyte-rich diffuse large B-cell lymphomas (T/HRBCLs).

Main Results:

  • Expression of cyclin D1, CD20, and CD68 was analyzed in lymphoma subtypes.
  • Cyclin D1 was detected in 44% of NLPHLs and 60% of T/HRBCLs.
  • S-IHC identified discrepancies in 42% of cases compared to single IHC, underscoring challenges in distinguishing tumor cells from histiocytes.

Conclusions:

  • S-IHC is a valuable technique for research and diagnostics, enabling comprehensive protein expression analysis in single tissue sections.
  • The method preserves tissue architecture, facilitating detailed phenotypic characterization of individual cells.
  • S-IHC demonstrates significant added value in complex cases like lymphomas where cell morphology can be ambiguous.
Abstract